Biology Reference
In-Depth Information
Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, Walker B, Lori F. 1999.
Control of HIV despite the discontinuation of antiretroviral therapy. N Engl J Med 340: 1683±
1684.
Maecker H, Dunn H, Suni M, Dhatamzas E, Pitcher C, Bunde T, Persaud N, Trigona W, Fu T,
Sinclair E, Bredt B, McCune J, Maino V, Kern F, Picker LJ. 2001. Use of overlapping peptide
mixtures as antigens for cytokine ¯ow cytometry. J Immunol Meth 255: 27±40.
Maino VC, Picker LJ. 1998. Identi®cation of functional subsets by ¯ow cytometry: intracellular
detection of cytokine expression. Cytometry 34: 207±215.
Maino VC, Suni MA, Wormsley SB, Carlo DJ, Wallace MR, Moss RB. 2000. Enhancement of
HIV type 1 antigen-speci®c CD4
T cell memory in subjects with chronic HIV type 1 infection
receiving an HIV type 1 immunogen. AIDS Res Hum Retroviruses 16: 539±547.
McAdam S, Kaleebu P, Krausa P, Goulder P, French N, Collin B, Blanchard T, Whitworth J,
McMichael A, Gotch F. 1998. Cross-clade recognition of p55 by cytotoxic T lymphocytes in
HIV-1 infection. AIDS 12: 571±579.
McMichael. 2000. Editorial overview: T cell responses to HIV. Curr Opin Immunol 12: 367±370.
McMichael AJ, Ogg G, Wilson J, Callan M, Hambleton S, Appay V, Kelleher T, Rowland-Jones S.
2000. Memory CD8
T cells in HIV infection. Philos Trans R Soc Lond B Biol Sci 355: 363±
367.
Mittler JE, Levin BR, Antia R. 1996. T-cell homeostasis, competition, and drift: AIDS as HIV-
accelerated senescence of the immune repertoire. J Acquir Immune De®c Syndr Hum Retrovirol
12: 233±248.
Musey LK, Krieger JN, Hughes JP, Schacker TW, Corey L, McElrath MJ. 1999. Early and per-
sistent human immunode®ciency virus type 1 (HIV-1)-speci®c T helper dysfunction in blood and
lymph nodes following acute HIV-1 infection. J Infect Dis 180: 278±284.
Picker LJ, Maino VC. 2000. The CD4() T cell response to HIV-1. Curr Opin Immunol 12: 381±
386.
Pitcher CJ, Quittner C, Peterson DM, Connors M, Koup RA, Maino VC, Picker LJ. 1999. HIV-1-
speci®c CD4
T cells are detectable in most individuals with active HIV-1 infection, but decline
with prolonged viral suppression [see comments]. Nat Med 5: 518±525.
Rinaldo Jr C, Liebmann J, Huang X, Fan Z, Al-Shboul Q, McMahon DK, Day RD, Riddler SA,
Mellors JW. 1999. Prolonged suppression of human immunode®ciency virus type 1 (HIV-1)
viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to
microbial antigens but not to HIV-1 antigens. J Infect Dis 179: 329±336.
Rosenberg ES, Walker BD. 1998. HIV type 1-speci®c helper T cells: a critical host defense. AIDS
Res Hum Retroviruses 14(Suppl 2): S143±S147.
Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. 1997.
Vigorous HIV-1-speci®c CD4
T cell responses associated with control of viremia. Science 278:
1447±1450.
Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, Blanchard T, Ariyoshi K,
Oyugi J, Ngugi E, Bwayo J, MacDonald KS, McMichael AJ, Plummer FA. 1998. Cytotoxic T
cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi [see
comments]. J Clin Invest 102: 1758±1765.
Schwartz D, et al. 1994. Absence of recoverable infectious virus and unique immune responses in an
asymptomatic HIV long-term survivor. AIDS Res Hum Retroviruses 12: 1703±1711.
Selin LK, Vergilis K, Welsh RM, Nahill SR. 1996. Reduction of otherwise remarkably stable virus-
speci®c cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 183: 2489±
2499.
Sester M, Sester U, Kohler H, Schneider T, Deml L, Wagner R, Mueller-Lantzsch N, Pees HW,
Meyerhans A. 2000. Rapid whole blood analysis of virus-speci®c CD4 and CD8 T cell responses
in persistent HIV infection. AIDS 14: 2653±2660.
